These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2491208)
21. Rapid degradation of neurotensin by stimulated rat mast cells. Cochrane DE; Carraway RE; Boucher W; Feldberg RS Peptides; 1991; 12(6):1187-94. PubMed ID: 1726119 [TBL] [Abstract][Full Text] [Related]
22. Calcium-dependent release of neuromedin N and neurotensin from mouse hypothalamus. Kitabgi P; De Nadai F; Cuber JC; Dubuc I; Nouel D; Costentin J Neuropeptides; 1990 Feb; 15(2):111-4. PubMed ID: 2080018 [TBL] [Abstract][Full Text] [Related]
23. Developmental changes in neurotensin and its metabolites in the neonatal rat. Bennett GW; Moss SH; Forster CD; Marsden CA Brain Res Dev Brain Res; 1998 Dec; 111(2):189-96. PubMed ID: 9838108 [TBL] [Abstract][Full Text] [Related]
24. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030 [TBL] [Abstract][Full Text] [Related]
25. Differential processing of the neurotensin/neuromedin N precursor in the mouse. Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD Peptides; 1990; 11(2):227-35. PubMed ID: 2356154 [TBL] [Abstract][Full Text] [Related]
26. Alcohol and fatty acid stimulation of neurotensin release from rat small intestine. Ferris CF; Armstrong MJ; George JK; Stevens CA; Carraway RE; Leeman SE Endocrinology; 1985 Mar; 116(3):1133-8. PubMed ID: 3971900 [TBL] [Abstract][Full Text] [Related]
27. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components. Hammer RA; Carraway RE; Leeman SE J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889 [TBL] [Abstract][Full Text] [Related]
28. Heterologous high yield expression and purification of neurotensin and its functional fragment in Escherichia coli. Tapaneeyakorn S; Ross S; Attrill H; Watts A Protein Expr Purif; 2010 Nov; 74(1):65-8. PubMed ID: 20600945 [TBL] [Abstract][Full Text] [Related]
29. Differential processing of pro-neurotensin/neuromedin N and relationship to pro-hormone convertases. Kitabgi P Peptides; 2006 Oct; 27(10):2508-14. PubMed ID: 16904237 [TBL] [Abstract][Full Text] [Related]
30. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal. Lee YC; Allen JM; Uttenthal LO; Roberts PM; Gill SS; Bloom SR Dig Dis Sci; 1985 Feb; 30(2):129-33. PubMed ID: 3838153 [TBL] [Abstract][Full Text] [Related]
31. Ontogeny of neurotensin in the fetal sheep. Read D; Shulkes A J Dev Physiol; 1991 Sep; 16(3):155-62. PubMed ID: 1797922 [TBL] [Abstract][Full Text] [Related]
32. Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1-8 and neurotensin1-10. Hernandez DE; Richardson CM; Nemeroff CB; Orlando RC; St-Pierre S; Rioux F; Prange AJ Brain Res; 1984 May; 301(1):153-6. PubMed ID: 6329440 [TBL] [Abstract][Full Text] [Related]
33. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases. Checler F; Vincent JP; Kitabgi P Eur J Pharmacol; 1986 Jul; 126(3):239-44. PubMed ID: 3019713 [TBL] [Abstract][Full Text] [Related]
34. A highly sensitive and selective radioimmunoassay for the measurement of neurotensin. Holtom PE; Wasuntarawat C; Moss SH; Aspley S; Needham PL; Bennett GW J Neurosci Methods; 2000 Jul; 100(1-2):151-6. PubMed ID: 11040378 [TBL] [Abstract][Full Text] [Related]
35. Neurotensin may function as a regulatory peptide in small cell lung cancer. Davis TP; Crowell S; McInturff B; Louis R; Gillespie T Peptides; 1991; 12(1):17-23. PubMed ID: 1646999 [TBL] [Abstract][Full Text] [Related]
36. Neurotensin and neuromedin N are differentially processed from a common precursor by prohormone convertases in tissues and cell lines. Kitabgi P Results Probl Cell Differ; 2010; 50():85-96. PubMed ID: 19862492 [TBL] [Abstract][Full Text] [Related]
37. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues. Lundquist JT; Dix TA Bioorg Med Chem Lett; 1999 Sep; 9(17):2579-82. PubMed ID: 10498212 [TBL] [Abstract][Full Text] [Related]
38. Precursor forms of neurotensin (NT) in cat: processing with pepsin yields NT-(3-13) and NT-(4-13). Carraway RE; Mitra SP Regul Pept; 1987 Aug; 18(3-4):139-54. PubMed ID: 3118422 [TBL] [Abstract][Full Text] [Related]
40. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor. Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]